Australia’s Future Fund Takes a Page from Alaska
Posted on 02/26/2016
The Alaska Permanent Fund Corporation (APFC) has made two notable large bets in anti-cancer pharmaceuticals. One of their strategic investments was in Juno Therapeutics. Biotech companies in areas such as anti-cancer therapies see wealth funds as ideal capital partners due to their long-term investment horizon. Waltham-based TESARO, Inc., an oncology-focused biopharmaceutical company, entered into definitive […]
- Alaska Permanent Fund Corporation
- Alternatives
- Australia
- Biotech
- Future Fund
- Juno Therapeutics
- pharmaceuticals
- Venture Capital
